Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML.
Saved in:
| Title: | Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML. |
|---|---|
| Authors: | Swain RN; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Jain A; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Wadhera S; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Singh C; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Jandial A; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Khadwal A; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Sachdeva MU; Department of Hematology, PGIMER, Chandigarh, India., Naseem S; Department of Hematology, PGIMER, Chandigarh, India., Malhotra P; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India., Prakash G; Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India. drgp04@gmail.com. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Apr 15; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
